1Kim WR, Poterucha J J, Porayko MK, et al. Recurrence of nonalcoholic steatohepatitis following liver transplantation.Transplantation, 1996,62 : 1802-1805.
2Samuel D, Muller R, Alexander G, et al.Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med, 1993, 329: 1842-1847.
3Perrillo R, Rakela J, Martin P, et al.Lamivudine for hepatitis B after liver transplantation [Abstract]. Hepatology,1996,24:182A.
4Chu CJ,Robert J,Fontana CM,et al. Outcome of liver transplantation for hepatitis B: report of a single center's experience.Liver Transpl, 2001,7 : 724-731.
5Paolo DD,Tisone G,Piccolo P,et al.Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine:a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.Transplantation 2004,77:1203-1208.
6Mutimer D,Pillay D.High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.J Hepatol,1999,30:715-721.
7Rosenau J,Bahr MJ,Tillmann HL,et al.Lamivudine and lowdose hepatitis B immunoglobulin for prophylaxis of hepatitis B reinfection after liver transplantation; possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.J Hepatol,2001,34:895-902.
